NCT01689038View on ClinicalTrials.gov

Brain Imaging Study of F17464

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Healthy Volunteers

Interventions

DRUG

F17464

Single dose

Trial Locations (1)

Unknown

New York

All Listed Sponsors

lead

Pierre Fabre Medicament

INDUSTRY

NCT01689038 - Brain Imaging Study of F17464 | Biotech Hunter | Biotech Hunter